Supernus Pharmaceuticals (SUPN) EBT Margin Growth (1y) (2012 - 2025)
Supernus Pharmaceuticals (SUPN) EBT Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 342.00 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -166.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,258.00 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1,049.00 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2,773.00 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 132.00 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -16,509.00 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1,555.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2,702.00 |
| 10 | Supernus Pharmaceuticals | 2.57 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,605.00 |
| Sep 30, 2025 | -5,575.00 |
| Jun 30, 2025 | -555.00 |
| Mar 31, 2025 | -406.00 |
| Dec 31, 2024 | 1,455.00 |
| Sep 30, 2024 | 1,915.00 |
| Jun 30, 2024 | 2,826.00 |
| Mar 31, 2024 | -570.00 |
| Dec 31, 2023 | -2,040.00 |
| Sep 30, 2023 | 668.00 |
| Jun 30, 2023 | -1,929.00 |
| Mar 31, 2023 | -379.00 |
| Dec 31, 2022 | 1,971.00 |
| Sep 30, 2022 | -1,976.00 |
| Jun 30, 2022 | -1,544.00 |
| Mar 31, 2022 | 131.00 |
| Dec 31, 2021 | -2,636.00 |
| Sep 30, 2021 | -1,447.00 |
| Jun 30, 2021 | -1,515.00 |
| Mar 31, 2021 | -2,222.00 |